Skip to main content

Table 1 Baseline demographic and clinical characteristics of study sample

From: Cognitive impairment and “invisible symptoms” are not associated with CCSVI in MS

  CCSVI- CCSVI+ p-value
N° (%) 34 27 0.3
W/M (%) 24 (70.5) 19 (70.3) 1.0
Age (mean ± SD) 42.3 ± 12.3 46.1 ± 11.1 0.3
EDSS (mean ± SD) 3.1 ± 2.8 3.0 ± 2.3 1.0
Disease Duration (years; mean ± SD ) 13 ± 9.9 13.7 ± 8.8 0.6
Mean Education (years; mean ± SD ) 11.9 ± 3.9 12.1 ± 4.6 0.7
RR (%) 19 (55.9) 17 (63.0) 0.5
SP (%) 9 (26.5) 3 (11.1) 0.2
PP (%) 2 (5.9) 5 (18.5) 0.2
CIS (%) 4 (11.8) 2 (7.4) 0.7
  1. Data are given as means ± standard deviations.
  2. W women.
  3. M men.
  4. RR relapsing-remitting.
  5. SP secondary progressive.
  6. PP primary progressive.
  7. CIS clinically isolated syndrome.